// insider-profile

Gentry Leesa

OfficerTitle: Chief Clinical OfficerView on SEC.gov ↗

// activity-summary

No insider transactions in the last 30 days.

// track-record

$0
Total purchased
$0
Total sold
0
0B · 0S transactions
Mixed
Overall direction
Filing history: Mar 2024 — Apr 2026Based on last 4 filings

Transaction History

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Apr 3, 2026Gentry LeesaRNXTAward128,550$0.00$0K
Jul 1, 2025Gentry LeesaRNXTAward6,619$0.00$0K
Apr 14, 2025Gentry LeesaRNXTAward26,477$0.00$0K
Mar 6, 2024Gentry LeesaRNXTAward190,000——